Alliance Pharma plc – LSE:APH.L

Alliance Pharma stock price today

GBP 108.8
+63
+137.55%
Financial Health
0
1
2
3
4
5
6
7
8
9

Alliance Pharma stock price monthly change

+22.13%
month

Alliance Pharma stock price quarterly change

+22.13%
quarter

Alliance Pharma stock price yearly change

+17.14%
year

Alliance Pharma key metrics

Market Cap
247.57M
Enterprise value
280.96M
P/E
-25.59
EV/Sales
1.65
EV/EBITDA
8.11
Price/Sales
1.06
Price/Book
0.65
PEG ratio
-264.11
EPS
-0.05
Revenue
348.09M
EBITDA
90.69M
Income
-32.2M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
-4.15%
Oper. margin
14.36%
Gross margin
51.58%
EBIT margin
14.36%
EBITDA margin
26.06%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Alliance Pharma stock price history

Alliance Pharma stock forecast

Alliance Pharma financial statements

Alliance Pharma plc (LSE:APH.L): Profit margin
Jun 2022 78.76M 13.10M 16.64%
Dec 2022 88.65M -12.16M -13.73%
Jun 2023 81.39M 5.10M 6.28%
Dec 2023 99.28M -38.24M -38.52%
Alliance Pharma plc (LSE:APH.L): Analyst Estimates
2027 214M 36.08M 16.86%
  • Analysts Price target

  • Financials & Ratios estimates

3.50%
Yield TTM
Alliance Pharma plc (LSE:APH.L): Payout ratio
Payout ratio -131.51%
Alliance Pharma plc (LSE:APH.L): Dividend Yield
2019 1.73%
2020 0.61%
2021 1.48%
2022 3.19%
2023 4.38%
Alliance Pharma plc (LSE:APH.L): Debt to assets
Jun 2022 548568000 251.63M 45.87%
Dec 2022 537411000 249.75M 46.47%
Jun 2023 513720000 236.76M 46.09%
Dec 2023 414923000 197.05M 47.49%
Alliance Pharma plc (LSE:APH.L): Cash Flow
Jun 2022 5.64M -16.03M 10.44M
Dec 2022 10.52M -993K -6.51M
Jun 2023 11.15M -406K -15.70M
Dec 2023 10.81M -512K -14.05M

Alliance Pharma alternative data

Alliance Pharma plc (LSE:APH.L): Employee count
Aug 2023 285
Sep 2023 285
Oct 2023 285
Nov 2023 285
Dec 2023 285
Jan 2024 285
Feb 2024 285
Mar 2024 285
Apr 2024 285
May 2024 285
Jun 2024 285
Jul 2024 292

Alliance Pharma other data

Insider Compensation
Mr. Peter Jonathan Butterfield (1976) Chief Executive Officer & Executive Director
$612,030
Mr. Andrew Timothy Franklin (1966) Chief Financial Officer & Executive Director
$349,230
  • What's the price of Alliance Pharma stock today?

    One share of Alliance Pharma stock can currently be purchased for approximately $108.8.

  • When is Alliance Pharma's next earnings date?

    Unfortunately, Alliance Pharma's (APH.L) next earnings date is currently unknown.

  • Does Alliance Pharma pay dividends?

    Yes, Alliance Pharma pays dividends and its trailing 12-month yield is 3.5% with -132% payout ratio.It means that the company is paying a dividend while loss making. The last Alliance Pharma stock dividend of $0.56 was paid on 7 Sep 2025.

  • How much money does Alliance Pharma make?

    Alliance Pharma has a market capitalization of 247.57M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 7.92% to 180.68M US dollars.

  • What is Alliance Pharma's stock symbol?

    Alliance Pharma plc is traded on the LSE under the ticker symbol "APH.L".

  • What is Alliance Pharma's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.

  • How do i buy shares of Alliance Pharma?

    Shares of Alliance Pharma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Alliance Pharma's key executives?

    Alliance Pharma's management team includes the following people:

    • Mr. Peter Jonathan Butterfield Chief Executive Officer & Executive Director(age: 49, pay: $612,030)
    • Mr. Andrew Timothy Franklin Chief Financial Officer & Executive Director(age: 59, pay: $349,230)
  • How many employees does Alliance Pharma have?

    As Jul 2024, Alliance Pharma employs 292 workers, which is 2% more then previous month and 2% more then previous quarter.

  • When Alliance Pharma went public?

    Alliance Pharma plc is publicly traded company for more then 23 years since IPO on 22 Nov 2001.

  • What is Alliance Pharma's official website?

    The official website for Alliance Pharma is alliancepharmaceuticals.com.

  • How can i contact Alliance Pharma?

    Alliance Pharma can be reached via phone at +44 1249 466966.

Alliance Pharma company profile:

Alliance Pharma plc

alliancepharmaceuticals.com
Exchange:

LSE

Full time employees:

290

Industry:

Drug Manufacturers - Specialty & Generic

Sector:

Healthcare

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. It holds the marketing rights of approximately 80 consumer healthcare and prescription medicine products. The company also offers medical devices, food supplements, and cosmetics. Alliance Pharma plc provides its products under the Aloclair, Anbesol, Asthon and Parsons, Atopiclair, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. The company was founded in 1996 and is headquartered in Chippenham, the United Kingdom.

Avonbridge House
Chippenham, SN15 2BB

:
ISIN: GB0031030819
CUSIP: G0179G102